Home » Topics » BioWorld Science

BioWorld Science
RSS

5-LO inhibitor approved by FDA

Dec. 13, 1996

NDA filed for Antizol

Dec. 13, 1996

Biomira strengthens patent rights to Mucin 1 cancer antigen

Dec. 13, 1996

Visible Genetics acquires BIOS Laboratories technology

Dec. 13, 1996

RSV MAb from MedImmune enters pivotal trials

Dec. 13, 1996

ADAC's Molecular Coincidence Detection shows promising results

Dec. 13, 1996

PLC Systems allowed to expand Heart Laser trials

Dec. 13, 1996

Atlantic Pharmaceuticals issued U.S. patent

Dec. 13, 1996

Positive phase IIa results for therapeutic vaccine for genital warts

Dec. 13, 1996

BioDelivery Sciences and Wyeth-Lederle Vaccines collaboration

Dec. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...